Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
European Journal of Pharmacology
|
February 14, 1991
A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury
H Masumura, S Kunitada, K Irie, et al.
Thrombosis and Haemostasis
|
May 6, 2011
Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux
M Wolzt, M M Samama, S Kapiotis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1991
A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction
D M Kerins, M Shuh, S Kunitada, et al.
Chemical & Pharmaceutical Bulletin
|
May 1, 1996
Amino acids and peptides. XXVII. Solid phase synthesis of fibrinogen-related peptides with disulfide bond formed on solid support
M Kakiuchi, Y Izuno, M Maeda, et al.
Advances in Cyclic Nucleotide Research
|
January 1, 1980
Adrenergic and cholinergic modulation of extracellular cyclic nucleotides
M Ui, M Honma, S Kunitada, et al.
Circulation
|
February 1, 1992
Pharmacokinetics of tissue-type plasminogen activator during acute myocardial infarction in men. Effect of a prostacyclin analogue
D M Kerins, L Roy, S Kunitada, et al.
Clinical Pharmacology and Therapeutics
|
October 8, 1999
Tolerability, pharmacokinetics, and pharmacodynamics of DX-9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers
N Murayama, M Tanaka, S Kunitada, et al.
Circulation
|
August 1, 1995
Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates
T Yokoyama, A B Kelly, U M Marzec, et al.
Thrombosis and Haemostasis
|
June 12, 1999
DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model
K Tanabe, Y Morishima, T Shibutani, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 6, 2004
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot
J H Alexander, C K Dyke, H Yang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
European Journal of Pharmacology
|
February 14, 1991
A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury
H Masumura, S Kunitada, K Irie, et al.
Thrombosis and Haemostasis
|
May 6, 2011
Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux
M Wolzt, M M Samama, S Kapiotis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1991
A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction
D M Kerins, M Shuh, S Kunitada, et al.
Chemical & Pharmaceutical Bulletin
|
May 1, 1996
Amino acids and peptides. XXVII. Solid phase synthesis of fibrinogen-related peptides with disulfide bond formed on solid support
M Kakiuchi, Y Izuno, M Maeda, et al.
Advances in Cyclic Nucleotide Research
|
January 1, 1980
Adrenergic and cholinergic modulation of extracellular cyclic nucleotides
M Ui, M Honma, S Kunitada, et al.
Circulation
|
February 1, 1992
Pharmacokinetics of tissue-type plasminogen activator during acute myocardial infarction in men. Effect of a prostacyclin analogue
D M Kerins, L Roy, S Kunitada, et al.
Clinical Pharmacology and Therapeutics
|
October 8, 1999
Tolerability, pharmacokinetics, and pharmacodynamics of DX-9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers
N Murayama, M Tanaka, S Kunitada, et al.
Circulation
|
August 1, 1995
Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates
T Yokoyama, A B Kelly, U M Marzec, et al.
Thrombosis and Haemostasis
|
June 12, 1999
DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model
K Tanabe, Y Morishima, T Shibutani, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 6, 2004
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot
J H Alexander, C K Dyke, H Yang, et al.
Page
of 2